KORU Medical Systems, Inc. (KRMD) - Form 8-K Summary
Business Context and Reporting Period
KORU Medical Systems, Inc. filed a Current Report on Form 8-K on January 13, 2025. The filing serves to announce preliminary financial results for the fiscal quarter and fiscal year ended December 31, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol KRMD.
Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document states that preliminary results are based on current estimates and remain subject to change upon completion of closing and review procedures. Detailed financial figures are contained in the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. It directs investors to the press release (Exhibit 99.1) for the announcement of these preliminary results.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure: The company posted an investor presentation (Exhibit 99.2) on January 13, 2025, which may be used in presentations to investors and analysts.
- Forward-Looking Statements: The company undertakes no duty or obligation to publicly update or revise the information in the investor presentation, though it may do so through future filings or press releases.
- Legal Status: The information in Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the specific preliminary revenue and net income figures in the press release (Exhibit 99.1) as they are not listed in the 8-K text.
- Confirm the final audited results once the closing and review procedures are completed, as current figures are estimates.
- Review the investor presentation (Exhibit 99.2) for management's qualitative outlook and strategic updates.
- Note that the filing date is January 13, 2025, covering the period ended December 31, 2024.